Aloja 12.5 Tablet

What is Aloja 12.5

Aloja 12.5 contains 12.5 mg FDA-approved Alogliptin, a selective Dipeptidyl Peptidase-4 (DPP-4) inhibitor for Type 2 Diabetes management. This oral medication enhances the body's natural ability to regulate blood glucose by increasing the Incretin hormone levels.

Alogliptin prevents the breakdown of GLP-1 and GIP hormones, improving Insulin secretion and reducing glucagon release. Indoco Remedies Ltd manufactures this antidiabetic medicine.

It works effectively as monotherapy or combination treatment alongside other Diabetes medications. Aloja offers glucose-dependent action, which primarily works when blood sugar levels are elevated.

Common side effects include Nasopharyngitis, headache, and upper respiratory infections. The medication demonstrates excellent tolerability with minimal Hypoglycemia risk when used alone. Pancreatitis, though rare, requires immediate medical attention if severe abdominal pain occurs.

Store Aloja tablets in their original packaging at room temperature below 30°C. Take medication consistently at the same time daily. Regular glucose monitoring helps assess treatment effectiveness and adjust therapy accordingly.

What are the benefits of Aloja 12.5

Aloja 12.5 provides glucose control through Alogliptin's selective DPP-4 inhibition mechanism. This action preserves endogenous incretin hormones that naturally regulate postprandial glucose levels. The medication stimulates Insulin release only when glucose levels are elevated, minimizing Hypoglycemia risk significantly.

Key therapeutic advantages include weight neutrality and stable glucose levels. Clinical studies demonstrate sustained HbA1c reductions with excellent long-term tolerability profiles.

The once-daily dosing convenience improves patient adherence and treatment satisfaction.

Aloja complements existing Diabetes regimens without increasing Hypoglycemia risk when combined with Metformin or lifestyle modifications.

Individuals benefit from improved quality of life through stable glucose control without weight gain concerns or frequent dosing requirements.

How to take Aloja 12.5

Aloja is a prescription medication that should be taken as prescribed. Here are the general administration guidelines:

• Take a tablet at the same time each day for optimal therapeutic effect.
• Swallow whole with water. Do not crush or split tablets.
• It can be taken with or without food as absorption remains unaffected.
• Do not discontinue medication or exceed the prescribed dosage without consulting your healthcare provider.

Strengths and substitutes

The strengths and substitutes available for Aloja at Cheap Medicine Shop are:

View all substitutes

What are the side effects of Aloja 12.5

Aloja is generally well-tolerated with minimal adverse effects. However, it may cause side effects, including:

• Nasopharyngitis
• Upper respiratory infections
• Headache
• Dizziness
• Gastrointestinal disturbances
• Joint pain
• Muscle aches

They are typically mild and resolve without requiring treatment discontinuation or medical intervention. Seek help if they worsen.

Safety Advice

Liver disease

Those with mild to moderate hepatic impairment can use Aloja without dose adjustments. However, severe liver disease requires careful evaluation and monitoring. Liver function tests should be performed before treatment initiation and monitored periodically during therapy to ensure medication safety. Consult a doctor before use.

Kidney impairment

Renal function significantly affects Alogliptin elimination. Patients with moderate kidney impairment (creatinine clearance 30-60 mL/min) require a dose reduction to 6.25 mg daily. Severe renal impairment or dialysis patients need further dose adjustments and enhanced monitoring for optimal safety. Consult a doctor before use.

Pregnant and breastfeeding women

Aloja 12.5 safety during pregnancy remains unestablished, with limited human data available. Insulin therapy is preferred for gestational Diabetes management. Breastfeeding mothers should avoid Alogliptin due to unknown excretion in breast milk and potential effects on nursing infants.

Avoid

Avoid alcohol in excess, as it may increase the risk of Hypoglycemia when combined with other antidiabetic medications. Do not use it with other DPP-4 inhibitors to prevent additive effects. Certain herbal supplements may interact with glucose metabolism and require medical consultation before use.